David M. Mannino

Q: What Schools Are Affiliated With David M. Mannino

David M. Mannino is affiliated with the following schools: University of California, Berkeley, Yale University, University of Kentucky, Stanford University, Columbia University

David M. Mannino's AcademicInfluence.com Rankings

David M. Mannino

Medical

#1050

World Rank

#1345

Historical Rank

Public Health

#127

World Rank

#134

Historical Rank

Epidemiology

#141

World Rank

#152

Historical Rank

medical Degrees

David M. Mannino

Engineering

#2385

World Rank

#3286

Historical Rank

Biomedical Engineering

#58

World Rank

#58

Historical Rank

Applied Physics

#298

World Rank

#308

Historical Rank

engineering Degrees

Download Badge

Medical
Engineering

David M. Mannino's Degrees

PhD Biomedical Engineering University of California, Berkeley
Masters Biomedical Engineering University of California, Berkeley
Bachelors Biomedical Engineering University of California, Berkeley

Why Is David M. Mannino Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David M. Mannino's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The epidemiology of sepsis in the United States from 1979 through 2000. (2003) (5904)
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study (2007) (2153)
Global burden of COPD: risk factors, prevalence, and future trends (2007) (1948)
Global burden of COPD: systematic review and meta-analysis (2006) (1487)
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. (2002) (1338)
Surveillance for asthma--United States, 1980-1999. (2002) (1276)
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD (2008) (1033)
Surveillance for asthma--United States, 1960-1995. (1998) (877)
The effect of age on the development and outcome of adult sepsis* (2006) (802)
Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. (2000) (770)
Epidemiology and costs of chronic obstructive pulmonary disease (2006) (731)
COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. (2002) (629)
Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. (2003) (605)
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study (2003) (601)
The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. (2009) (554)
Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. (2005) (399)
Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. (2012) (362)
The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. (2003) (345)
The role of infection and comorbidity: Factors that influence disparities in sepsis (2006) (334)
Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. (2003) (334)
Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. (2006) (334)
Gender and chronic obstructive pulmonary disease: why it matters. (2007) (333)
Clinical and Radiologic Disease in Smokers With Normal Spirometry. (2015) (327)
Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. (2003) (322)
Ageing and the epidemiology of multimorbidity (2014) (321)
Body mass index and asthma severity in the National Asthma Survey (2007) (317)
COPD as a Lung Disease with Systemic Consequences – Clinical Impact, Mechanisms, and Potential for Early Intervention (2008) (298)
The natural history of chronic obstructive pulmonary disease (2006) (291)
What is asthma−COPD overlap syndrome? Towards a consensus definition from a round table discussion (2016) (282)
COPD Surveillance—United States, 1999-2011 (2013) (282)
Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. (2003) (279)
The epidemiology of sepsis in patients with malignancy. (2006) (255)
The epidemiology and economics of chronic obstructive pulmonary disease. (2007) (249)
Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry (2017) (240)
Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? (2006) (236)
Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. (2006) (236)
COPD in Never Smokers (2011) (235)
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. (2009) (228)
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. (2009) (228)
Do insomnia complaints cause hypertension or cardiovascular disease? (2007) (215)
Health effects related to environmental tobacco smoke exposure in children in the United States: data from the Third National Health and Nutrition Examination Survey. (2001) (214)
Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. (1997) (210)
Involuntary smoking and asthma severity in children: data from the Third National Health and Nutrition Examination Survey. (2002) (209)
Asthma mortality in U.S. Hispanics of Mexican, Puerto Rican, and Cuban heritage, 1990-1995. (2000) (205)
Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty—a BOLD analysis (2013) (201)
Cigarette smoking: an independent risk factor for impotence? (1994) (201)
Results From the Population-Based Burden of Obstructive Lung Disease Study (2011) (198)
Epidemiology and prevalence of chronic obstructive pulmonary disease. (2014) (195)
Air Pollution and Heart Rate Variability Among the Elderly in Mexico City (2003) (194)
What constitutes an adverse health effect of air pollution (2000) (191)
Race and gender differences in acute respiratory distress syndrome deaths in the United States: An analysis of multiple-cause mortality data (1979–1996)* (2002) (191)
International Journal of Copd (191)
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. (2015) (190)
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease (2012) (188)
Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. (2004) (184)
Boys with high body masses have an increased risk of developing asthma: findings from the National Longitudinal Survey of Youth (NLSY) (2006) (182)
Lung function decline and outcomes in an elderly population (2005) (178)
Lung function impairment, COPD hospitalisations and subsequent mortality (2008) (176)
COPD and gender differences: an update. (2013) (175)
Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. (2005) (170)
Economic Burden of COPD in the Presence of Comorbidities (2015) (168)
Comorbidities in chronic obstructive pulmonary disease. (2008) (164)
C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. (2003) (159)
Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort (2008) (159)
Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013 (2014) (155)
Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. (2013) (154)
Chronic obstructive pulmonary disease: definition and epidemiology. (2003) (154)
National vehicle emissions policies and practices and declining US carbon monoxide-related mortality. (2002) (151)
Cardiorespiratory hospitalizations associated with smoke exposure during the 1997, Southeast Asian forest fires. (2005) (151)
Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey (2004) (151)
Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. (1999) (146)
C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults (2003) (146)
Wildland forest fire smoke: health effects and intervention evaluation, Hoopa, California, 1999. (2002) (145)
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD (2015) (145)
Tuberculosis associates with both airflow obstruction and low lung function: BOLD results (2015) (145)
Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data. (1996) (140)
Burden and pathogenesis of chronic obstructive pulmonary disease. (2009) (140)
Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes (2014) (137)
Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. (2013) (137)
Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study (2009) (136)
Self-reported asthma and health-related quality of life: findings from the behavioral risk factor surveillance system. (2003) (133)
Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. (1996) (133)
Racial and ethnic disparities in asthma medication usage and health-care utilization: data from the National Asthma Survey. (2009) (131)
Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality. (2015) (129)
Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians (2011) (127)
Body mass index and asthma incidence among USA adults (2004) (125)
A controlled trial of an environmental tobacco smoke reduction intervention in low-income children with asthma. (2001) (120)
Changing the burden of COPD mortality (2006) (119)
Lung function decline and outcomes in an adult population. (2006) (118)
Country of birth as a risk factor for asthma among Mexican Americans. (2005) (117)
Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries (2016) (117)
Intravenous fat emulsions and lung function: A review (1988) (111)
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD (2015) (109)
Asthma, Chronic Obstructive Pulmonary Disease, and Mortality in the U.S. Population (2011) (109)
Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history (2015) (109)
Incidence and cost of pneumonia in medicare beneficiaries. (2012) (104)
Interventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations. A systematic review. (2014) (103)
Predictors of cotinine levels in US children: data from the Third National Health and Nutrition Examination Survey. (2001) (102)
Sociodemographic correlates of indoor allergen sensitivity among United States children. (2001) (101)
Leisure-time physical activity patterns among US adults with asthma. (2003) (101)
Environmental tobacco smoke exposure and health effects in children: results from the 1991 National Health Interview Survey. (1996) (100)
Correlates of sleep complaints in adults: the ARIC study. (2005) (100)
Cigarette smoking and thyroid hormone levels in males. (1997) (97)
Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. (2001) (96)
Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. (2008) (96)
Serum carotenoid concentrations in US children and adolescents. (2002) (95)
Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. (2005) (95)
Risk factors for asthma incidence. A review of recent prospective evidence. (2004) (94)
A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease (2017) (94)
Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. (2005) (94)
Defining and targeting health disparities in chronic obstructive pulmonary disease (2016) (94)
A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease (2017) (94)
Population distribution of high-sensitivity C-reactive protein among US men: findings from National Health and Nutrition Examination Survey 1999-2000. (2003) (92)
Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium. (2016) (92)
Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. (2003) (91)
Does insomnia kill? (2005) (91)
Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD. (2015) (91)
Asthma prevalence among US adults, 1998-2000: role of Puerto Rican ethnicity and behavioral and geographic factors. (2006) (87)
Second-hand Smoke Exposure and Blood Lead Levels in U.S. Children (2003) (87)
Chronic Obstructive Pulmonary Disease and Asthma–Patient Characteristics and Health Impairment (2013) (86)
Nitrogen and energy relationships in malnourished patients with emphysema. (1988) (86)
Dietary intake, physical activity, body mass index, and childhood asthma in the third national health and nutrition survey (NHANES III) (2004) (85)
Energy expenditure in patients with chronic obstructive pulmonary disease. (1987) (85)
Reduction in asthma-related emergency department visits after implementation of a smoke-free law. (2008) (85)
Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial (2012) (84)
Extended indications for lung volume reduction surgery in advanced emphysema. (1996) (84)
Increasing U.S. Asthma Mortality Rates: Who Is Really Dying? (2001) (83)
Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality. (2012) (82)
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease (2018) (82)
Outdoor and indoor air pollution and COPD-related diseases in high- and low-income countries. (2008) (81)
Epidemiology of Chronic Obstructive Pulmonary Disease: Prevalence, Morbidity, Mortality, and Risk Factors (2015) (80)
COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. (2019) (80)
Lung volumes before and after lung volume reduction surgery: quantitative CT analysis. (1998) (79)
Association between right ventricular function and perfusion abnormalities in hemodynamically stable patients with acute pulmonary embolism. (1998) (77)
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. (2016) (75)
Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction (2009) (75)
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. (2016) (75)
Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005). (2009) (74)
Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). (2010) (74)
Worldwide epidemiology of chronic obstructive pulmonary disease. (1999) (73)
Pulmonary Fibrosis and Lung Cancer in the United States: Analysis of the Multiple Cause of Death Mortality Data, 1979 Through 1991 (1996) (72)
Functional comparison of unilateral versus bilateral lung volume reduction surgery. (1997) (72)
Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study (2012) (72)
A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases (2011) (71)
Cigarette smoking and health. American Thoracic Society. (1996) (70)
Restricted spirometry in the Burden of Lung Disease Study. (2012) (70)
Epidemiology and global impact of chronic obstructive pulmonary disease. (2005) (70)
National and State Estimates of COPD Morbidity and Mortality - United States, 2014-2015. (2018) (69)
Characteristics of adults dying with COPD. (2002) (68)
Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study (2011) (68)
Environmental tobacco smoke exposure in the home and worksite and health effects in adults: results from the 1991 National Health Interview Survey. (1997) (66)
Determinants of Quality of Life Among People with Asthma: Findings from the Behavioral Risk Factor Surveillance System (2004) (66)
Occupational exposures and COPD: an ecological analysis of international data (2008) (66)
COPD as a disease of children: hype or hope for better understanding? (2010) (65)
Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. (2009) (63)
Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries (2014) (61)
Time Trends in Obesity Among Adults with Asthma in the United States: Findings from Three National Surveys (2004) (59)
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease (2021) (58)
Relationship Between Asthma, Overweight, And Physical Activity Among U.S. High School Students (2006) (57)
Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, Recommendations of the COPD Foundation (2013) (56)
Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, Recommendations of the COPD Foundation (2013) (56)
Trends and patterns of mortality associated with birth defects and genetic diseases in the United States, 1979–1992: An analysis of multiple‐cause mortality data (1997) (55)
Socioeconomic disparities in secondhand smoke exposure among US never-smoking adults: the National Health and Nutrition Examination Survey 1988–2010 (2014) (53)
Respiratory Symptoms in Young Adults and Future Lung Disease. The CARDIA Lung Study (2018) (52)
COPD prevalence in southeastern Kentucky: the burden of lung disease study. (2009) (51)
Asthma Phenotypes, Risk Factors, and Measures of Severity in a National Sample of US Children (2005) (51)
The role of body mass index and diabetes in the development of acute organ failure and subsequent mortality in an observational cohort (2006) (50)
Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. (2014) (50)
Sarcoidosis-Associated Fibrosing Mediastinitis with Resultant Pulmonary Hypertension: A Case Report and Review of the Literature (2009) (50)
Overdiagnosis of COPD in Subjects With Unobstructed Spirometry: A BOLD Analysis. (2019) (50)
Defining chronic obstructive pulmonary disease… and the elephant in the room (2007) (50)
Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts (2012) (49)
Active and passive smoking and blood lead levels in U.S. adults: data from the Third National Health and Nutrition Examination Survey. (2005) (49)
How much asthma is occupationally related? (2000) (49)
Expression of Egr-1 in late stage emphysema. (2000) (49)
Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. (2012) (48)
Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. (2012) (48)
Fibrinogen, COPD and Mortality in a Nationally Representative U.S. Cohort (2012) (47)
Alcohol intake is associated with altered pulmonary function. (2005) (47)
Serum Antioxidant Concentrations Among U.S. Adults with Self‐Reported Asthma (2004) (47)
Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis. (2017) (46)
Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies. (2014) (46)
Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies. (2014) (46)
The Relationship between Dietary Fiber Intake and Lung Function in the National Health and Nutrition Examination Surveys. (2016) (45)
Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease. (2015) (44)
Analysis of Hospitalizations for COPD Exacerbation: Opportunities for Improving Care (2010) (43)
The effect of sex on asthma control from the National Asthma Survey. (2009) (42)
Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 1988-1994. (2012) (42)
Airway obstructive diseases in older adults: from detection to treatment. (2010) (42)
Association of ambient ozone exposure with airway inflammation and allergy in adults with asthma. (2009) (41)
Lung reduction operation and resection of pulmonary nodules in patients with severe emphysema. (1998) (41)
Association of smoking and chronic pain syndromes in Kentucky women. (2011) (41)
Exposure to Indoor Biomass Fuel Pollutants and Asthma Prevalence in Southeastern Kentucky: Results From the Burden of Lung Disease (BOLD) Study (2010) (40)
The association of adverse pregnancy events and cardiovascular disease in women 50 years of age and older. (2011) (40)
Asthma and influenza vaccination: findings from the 1999-2001 National Health Interview Surveys. (2003) (40)
Lobar Emphysema Distribution Is Associated With 5‐Year Radiological Disease Progression (2018) (40)
Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007–2010 (2012) (39)
Prevalence and Population Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study. (2020) (39)
Pharmacotherapy for Non‐Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry (2017) (39)
Molecular and clinical diseasome of comorbidities in exacerbated COPD patients (2015) (39)
Subjects with Discordant Airways Obstruction: Lost between Spirometric Definitions of COPD (2011) (38)
Walking abnormalities are associated with COPD: An investigation of the NHANES III dataset. (2011) (37)
Emergency department visits and hospitalizations for respiratory disease on the island of Hawaii, 1981 to 1991. (1996) (37)
The safety, efficacy, and durability of lung-volume reduction surgery: A 10-year experience. (2016) (37)
The effect of mold sensitization and humidity upon allergic asthma (2013) (37)
Lung cancer deaths in the United States from 1979 to 1992: an analysis using multiple-cause mortality data. (1998) (36)
Incidence and cost of CAP in a large working-age population. (2012) (36)
Health-related quality of life and chronic obstructive pulmonary disease in North Carolina (2010) (35)
Outcomes of severe COPD exacerbations requiring hospitalization. (2010) (35)
Forced expiratory volume in 1 second and physical activity in the general population. (2004) (35)
Association between Cardiorespiratory Fitness and Lung Health from Young Adulthood to Middle Age (2017) (34)
The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide. (2017) (34)
Sex differences in COPD and lung cancer mortality trends--United States, 1968-1999. (2004) (34)
Integrating COPD into Patient-Centered Hospital Readmissions Reduction Programs. (2015) (33)
Fewer hospitalizations for chronic obstructive pulmonary disease in communities with smoke-free public policies. (2014) (33)
Prevalence of COPD among symptomatic patients in a primary care setting (2009) (33)
The evaluation and preparation of the patient for lung volume reduction surgery. (2008) (33)
The Role of Income in Reducing Racial and Ethnic Disparities in Emergency Room and Urgent Care Center Visits for Asthma—United States, 2001–2009 (2011) (33)
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. (2002) (31)
Tobacco and other drug use among high school students with asthma. (2006) (30)
Airway responsiveness and job selection: a study in coal miners and non-mining controls. (1995) (30)
Diffuse intrapulmonary hemorrhage, renal failure and a systemic vasculitis. A case report and review of the literature. (1980) (30)
Hospitalization for patients with sarcoidosis: 1979-2000. (2006) (29)
Effects of GOLD-Adherent Prescribing on COPD Symptom Burden, Exacerbations, and Health Care Utilization in a Real-World Setting. (2015) (29)
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry. (2019) (29)
Lung-volume reduction surgery for pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year. (2007) (28)
Lung cancer mortality rates in birth cohorts in the United States from 1960 to 1994. (2001) (28)
Gender and asthma-chronic obstructive pulmonary disease overlap syndrome (2016) (28)
24/7 in-house intensivist coverage and fellowship education: a cross-sectional survey of academic medical centers in the United States. (2012) (27)
Feasibility and Acceptability of Utilizing a Smartphone Based Application to Monitor Outpatient Discharge Instruction Compliance in Cardiac Disease Patients around Discharge from Hospitalization (2014) (27)
Defining COPD-Related Comorbidities, 2004-2014. (2014) (27)
Prevalence and Outcomes of Diabetes, Hypertension, and Cardiovascular Disease in Chronic Obstructive Pulmonary Disease (2008) (27)
Prevalence of airway obstruction assessed by lung function questionnaire. (2011) (27)
Economic Burden of Chronic Obstructive Pulmonary Disease by Presence of Comorbidities (2015) (27)
Lung volume reduction surgery using the NETT selection criteria. (2011) (27)
Recent trends in exposure to secondhand smoke in the United States population (2010) (26)
What is the Cost to Employers of Direct Medical Care for Chronic Obstructive Pulmonary Disease? (2006) (25)
Alpha 1-antitrypsin deficiency deaths in the United States from 1979-1991. An analysis using multiple-cause mortality data. (1996) (25)
Reversing concepts on COPD irreversibility (2008) (24)
Cystic fibrosis deaths in the United States from 1979 through 1991. An analysis using multiple-cause mortality data. (1996) (24)
Do the medical history and physical examination predict low lung function? (1993) (24)
Human exposure to volatile organic compounds: a comparison of organic vapor monitoring badge levels with blood levels (1995) (24)
Functional changes during nutritional repletion in patients with lung disease. (1986) (23)
Appropriateness of Newborn Screening for α1-Antitrypsin Deficiency (2014) (23)
Coexisting asthma and COPD: confused clinicians or poor prognosticator? (2008) (23)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE OLDER ADULT: WHAT BEST DEFINES ABNORMAL LUNG FUNCTION? (2006) (23)
Optoelectronic plethysmography compared to spirometry during maximal exercise (2013) (23)
The Prevalence and Significance of Staphylococcus aureus in Patients with Non‐Cystic Fibrosis Bronchiectasis (2018) (23)
Occupational chronic obstructive pulmonary disease: an update. (2012) (23)
The Prevalence and Significance of Staphylococcus aureus in Patients with Non‐Cystic Fibrosis Bronchiectasis (2018) (23)
Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease (2019) (23)
Exercise ventilatory kinematics in endurance trained and untrained men and women (2011) (22)
Complete transection of the intrathoracic trachea due to blunt trauma. (1984) (22)
Continuing to Confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management (2015) (22)
Factors that impact medical student and house-staff career interest in brain related specialties (2016) (22)
Lung Disease and Asthma Severity in Adults with Asthma: Data from the Third National Health and Nutrition Examination (2005) (21)
Adverse Childhood Experiences and Adult Smoking, Nebraska, 2011 (2013) (21)
Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey (2016) (21)
Adult Bronchiectasis Patients: A First Look at the United States Bronchiectasis Research Registry. (2016) (21)
Risk Factors for Targeted Fungal and Mycobacterial Infections in Patients Taking Tumor Necrosis Factor Inhibitors (2015) (21)
Exposure to loud noise, bilateral high-frequency hearing loss and coronary heart disease (2015) (21)
Prescription Practices for Chronic Obstructive Pulmonary Disease: Findings from the National Ambulatory Medical Care Survey 1999–2010 (2014) (21)
Tobacco Use: A Chronic Illness? (2010) (20)
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for its Revision. (2022) (20)
Body mass index, asthma and exhaled nitric oxide in U.S. Adults, 2007–2010 (2014) (19)
Asthma-COPD overlap and chronic airflow obstruction: definitions, management, and unanswered questions. (2019) (19)
GOLD stage 0 COPD: is it real? Does it matter? (2006) (19)
Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD (2016) (19)
Submaximal exercise in emphysema and malnutrition at two levels of carbohydrate and fat intake. (1989) (18)
Reconsidering the Utility of Race-Specific Lung Function Prediction Equations. (2021) (18)
Different types of housing and respiratory health outcomes (2016) (18)
Disease Progression Modelling in Chronic Obstructive Pulmonary Disease (COPD). (2020) (18)
Women and chronic obstructive pulmonary disease: does sex influence survival? (2006) (18)
Asthma and Chronic Obstructive Pulmonary Disease Overlap: The Effect of Definitions on Measures of Burden. (2017) (17)
Influenza vaccination coverage among adults with asthma: findings from the 2000 Behavioral Risk Factor Surveillance System. (2004) (17)
Identifying cases of undiagnosed, clinically significant COPD in primary care: qualitative insight from patients in the target population (2015) (17)
Regional Differences in Hospitalizations for Asthma in the United States, 1988–1996 (2002) (17)
ADRB2 Arg16Gly Polymorphism, Lung Function, and Mortality: Results from the Atherosclerosis Risk in Communities Study (2007) (17)
Socioeconomic Characteristics Are Major Contributors to Ethnic Differences in Health Status in Obstructive Lung Disease: An Analysis of the National Health and Nutrition Examination Survey 2007-2010. (2015) (17)
Identifying cases of undiagnosed, clinically significant COPD in primary care: qualitative insight from patients in the target population (2015) (17)
Weight-loss practices and asthma: findings from the behavioral risk factor surveillance system. (2003) (17)
The Bronchiectasis Research Registry: A Collaborative Research Cohort For Non-Cystic Fibrosis Bronchiectasis (2012) (16)
Are Oxygenated Fuels Effective? An Evaluation of Ambient Carbon Monoxide Concentrations in 11 Western States, 1986 to 1992. (1996) (16)
Looking beyond the cigarette in COPD. (2008) (16)
Occupational Noise Exposure, Bilateral High-Frequency Hearing Loss, and Blood Pressure (2017) (16)
Community Size and Organization of Practice Predict Family Physician Recertification Success (2014) (16)
Individual and occupational characteristics associated with respiratory symptoms among Latino horse farm workers. (2015) (16)
Reducing COPD readmissions: great promise but big problems. (2015) (15)
Significant Bronchodilator Responsiveness and “Reversibility” in a Population Sample (2010) (15)
Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort (2013) (15)
Reducing COPD readmissions: great promise but big problems. (2015) (15)
Association of Ambient Ozone Exposure with Airway Inflammation and Allergy in Adults with Asthma (2009) (14)
Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty: a BOLD analysis—authors’ reply (2014) (14)
Comparing Patients with ZZ Versus SZ Alpha-1 Antitrypsin Deficiency: Findings from AlphaNet's Disease Management Program. (2018) (14)
Obstructive lung disease in Mexican Americans and non-Hispanic whites: an analysis of diagnosis and survival in the National Health and Nutritional Examination Survey III Follow-up Study. (2014) (14)
Epidemiology of COPD Exacerbations (2008) (13)
Epidemiology of comorbidities in chronic obstructive pulmonary disease: clusters, phenotypes and outcomes (2012) (13)
Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade (2021) (13)
Differences in gas exchange between severities of chronic obstructive pulmonary disease (2013) (13)
Impact of donor lung pathogenic bacteria on patient outcomes in the immediate post‐transplant period (2018) (13)
Relation between patent foramen ovale and perfusion abnormalities in acute pulmonary embolism. (1997) (13)
Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians (2011) (13)
Chronic Obstructive Pulmonary Disease: Epidemiology and Evaluation (2001) (13)
The effect of lung volume reduction surgery on chronotropic incompetence. (2012) (13)
Gender and COPD: Why it matters. (2007) (13)
Insight into Best Variables for COPD Case Identification: A Random Forests Analysis. (2016) (13)
Inflammatory markers and mortality among US adults with obstructive lung function (2015) (13)
Insight into Best Variables for COPD Case Identification: A Random Forests Analysis. (2016) (13)
Prevalence of COPD and comorbidity (2013) (13)
Biomarkers for chronic obstructive pulmonary disease diagnosis and progression: insights, disappointments and promise (2019) (12)
Lifetime risk of COPD: what will the future bring? (2011) (12)
An Of fi cial American Thoracic Society / European Respiratory Society Statement : Research Questions in Chronic Obstructive Pulmonary Disease (2015) (12)
Airway clearance techniques in bronchiectasis: Analysis from the United States Bronchiectasis and NTM Research Registry. (2020) (12)
Should we be using statistics to define disease? (2008) (12)
Trends in the Use, Sociodemographic Correlates, and Undertreatment of Prescription Medications for Chronic Obstructive Pulmonary Disease among Adults with Chronic Obstructive Pulmonary Disease in the United States from 1999 to 2010 (2014) (12)
Biomarkers in COPD: the search continues! (2015) (12)
Chronic obstructive pulmonary disease in 2025: where are we headed? (2005) (12)
Impact factor, impact, and smoke and mirrors. (2005) (12)
Race-ethnicity as an effect modifier of the association between HbAlc and mortality in U.S. adults without diagnosed diabetes. (2011) (12)
A case study and national database report of progressive systemic sclerosis and associated conditions. (1998) (11)
COUNTERPOINT: Can Screening for COPD Improve Outcomes? No. (2020) (11)
Systemic supply to a pulmonary arteriovenous malformation: a relative contraindication to surgery. (1985) (11)
Ventilatory Efficiency Before and After Lung Volume Reduction Surgery (2015) (11)
24/7 In-House Intensivist Coverage And Fellowship Education: A Cross Sectional Survey Of Academic Medical Centers In The United States (2011) (11)
COUNTERPOINT: Can Screening for COPD Improve Outcomes? No. (2020) (11)
Underdiagnosed chronic obstructive pulmonary disease in England: new country, same story (2006) (11)
A new approach to classification of disease severity and progression of COPD. (2013) (11)
COPD and lung cancer have come a long way ...baby. (2007) (11)
Role of Stress and Smoking as Modifiable Risk Factors for Nonpersistent and Persistent Back Pain in Women (2016) (11)
Trends in asthma mortality. Asthma mortality in United States has risen but is similar to that in England and Wales. (1997) (10)
COPD and Rural Health: A Dialogue on the National Action Plan (2019) (10)
Is it time to move beyond the “O” in early COPD? (2015) (10)
Chronotropic incompetence predicts mortality in severe obstructive pulmonary disease (2013) (10)
Investigation of the Correlates and Effectiveness of a Prison-Based Wellness Program (2012) (10)
Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease. (2018) (10)
Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD) (2016) (9)
Benefits Among Patients with Alpha-1 Antitrypsin Deficiency Enrolled in a Disease Management and Prevention Program. (2016) (9)
Vitamin D deficiency is associated with respiratory symptoms and airway wall thickening in smokers with and without COPD: a prospective cohort study (2020) (9)
Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease (2019) (9)
Pneumoconiosis: comparison of digitized and conventional radiographs. (1993) (9)
Characteristics of Chronic Obstructive Pulmonary Disease (COPD) Patients Reporting Alpha-1 Antitrypsin Deficiency in the WebMD Lung Health Check Database. (2015) (9)
Characteristics of Chronic Obstructive Pulmonary Disease (COPD) Patients Reporting Alpha-1 Antitrypsin Deficiency in the WebMD Lung Health Check Database. (2015) (9)
Spirometric screening: does it work? (2006) (9)
Obstructive Lung Disease Models: What Is Valid? (2008) (9)
Counting costs in COPD: what do the numbers mean? (2015) (9)
Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study. (2022) (8)
Respiratory Diseases Research at NIOSH: Reviews of Research Programs of the National Institute for Occupational Safety and Health (2008) (8)
Epidemiology and global impact of chronic obstructive pulmonary disease (2006) (8)
Optimizing bronchodilator therapy in emphysema. (2008) (8)
Why Won't Our Patients Stop Smoking? (2009) (7)
Recruiting Patients After Hospital Discharge for Acute Exacerbation of COPD: Challenges and Lessons Learned. (2017) (7)
Does Undiagnosed Chronic Obstructive Pulmonary Disease Matter? (2016) (7)
Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations (2017) (7)
The 2nd National COPD Readmissions Summit and Beyond: From Theory to Implementation. (2016) (7)
New Adopters of Telemedicine During the Coronavirus-19 Pandemic in Respondents to an Online Community Survey: The Case for Access to Remote Management Tools for Individuals with Chronic Obstructive Pulmonary Disease. (2020) (7)
Protocol Summary of the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) Validation in Primary Care Study (2021) (7)
Protocol Summary of the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) Validation in Primary Care Study (2021) (7)
Authors' reply [4] (2007) (7)
Necrotizing sarcoid granulomatosis with skin and pulmonary involvement. (2007) (7)
GOLD Stage 0 COPD (2006) (7)
Mucus plugging on computed tomography and chronic bronchitis in chronic obstructive pulmonary disease (2021) (6)
In-Hospital Mortality and Costs Related to Idiopathic Pulmonary Fibrosis Between 1993 and 2008 (2011) (6)
Patient Adherence in COPD: the Greatest Challenge (2007) (6)
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations (2021) (6)
Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment? (2018) (6)
Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance (2015) (6)
Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment? (2018) (6)
Frequency of untreated hypogammaglobulinemia in bronchiectasis. (2017) (6)
Performance of a Brief, Self-Administered Questionnaire (Lung Function Questionnaire) To Identify Patients at Risk of Airflow Obstruction as Potential Candidates for Spirometry: Scoring and Cut Point. (2009) (6)
COPD in Africa: the coming storm. (2013) (6)
Does Evaluation and Management of COPD Follow Therapeutic Strategy Recommendations? (2021) (6)
Diseases associated with restrictive lung function impairment (2009) (6)
SERIES ‘‘THE GLOBAL BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE’’ #3: The global burden of COPD: the natural history of COPD (2006) (5)
A comparison of single breath and re-breathe diffusing capacity in emphysema patients and controls (2012) (5)
Non‐invasive measurement of abnormal ventilatory mechanics in amyotrophic lateral sclerosis (2016) (5)
Doc, my asthma (depression) has gotten me down (wheezing). (2008) (5)
Will Recommendations against Spirometry Make Chronic Obstructive Pulmonary Disease Harder to Treat? (2008) (5)
The COPD Foundation: Celebrating a Decade of Progress and Looking Ahead to a Cure. (2014) (5)
Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial. (2021) (5)
Exposure to biogenic silica fibers and respiratory health in Hawaii sugarcane workers. (1994) (5)
Nutrition and Markers of Disease Severity in Patients With Bronchiectasis. (2020) (5)
Pulmonary function among Latino thoroughbred horse farmworkers (2017) (5)
Gender Specific Differences in the Pros and Cons of Smoking among Current Smokers in Eastern Kentucky: Implications for Future Smoking Cessation Interventions (2008) (5)
Tobacco and Other Drug Use Among High School Students with Asthma (2006) (5)
Understanding COPD hospitalizations: the devil is always in the details! (2007) (5)
Systemic inflammation in patients with chronic obstructive pulmonary disease: one size no longer fits all! (2012) (5)
Ethical issues related to clinical research and rare diseases (2017) (4)
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD (4)
The COPD Foundation Pocket Consultant Guide. (2014) (4)
Measuring asthma, respiratory symptoms, and changes over time. (2004) (4)
Susceptibility to Chronic Obstructive Pulmonary Disease (2003) (4)
Smoking and Emphysema: Looking Beyond the Cigarette. (2015) (4)
Association of birthplace and occupational exposures with chronic bronchitis in US Hispanics/Latinos, 2008–2011 (2020) (4)
PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ARE AT HIGHER RISK OF SEPSIS (2005) (4)
Introducing the New COPD Pocket Consultant Guide App: Can A Digital Approach Improve Care? A Statement of the COPD Foundation. (2019) (4)
EASE AND CORRECT USE OF ELLIPTA BY AGE IN PATIENTS WITH ASTHMA AND COPD (2018) (4)
The natural history of chronic obstructive pulmonary disease. (2011) (4)
Respiratory disease in 2010: looking to the past will prepare us for the future (2010) (4)
Characteristics of adults dying with Chronic Obstructive Pulmonary Disease (2002) (4)
Quantification of Improvements in Static and Dynamic Ventilatory Measures Following Lung Volume Reduction Surgery for Severe COPD. (2015) (4)
Development of a spirometry T-score in the general population (2016) (4)
HEALTH EFFECTS OF ENVIRONMENTAL TOBACCO SMOKE EXPOSURE AMONG CHILDREN IN THE US: RESULTS FROM NHANES III (1998) (4)
The COPD Foundation Pocket Consultant Guide. (2014) (4)
Introducing the New COPD Pocket Consultant Guide App: Can A Digital Approach Improve Care? A Statement of the COPD Foundation. (2019) (4)
Counting Costs in COPD * *From the Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health. (2015) (4)
Global Initiative on Obstructive Lung Diseases (GOLD) classification of COPD and incident lung cancer: findings from a cohort study (2004) (3)
A rapidly changing understanding of COPD - World COPD Day from the COPD Foundation. (2021) (3)
A rapidly changing understanding of COPD - World COPD Day from the COPD Foundation. (2021) (3)
Chronic Respiratory Disease, Comorbid Cardiovascular Disease, And Mortality In A Representative U.S. Cohort (2012) (3)
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of the IMPACT Trial. (2020) (3)
Fifty Years of Progress in the Epidemiology of Chronic Obstructive Pulmonary Disease: A Review of National Heart, Lung, and Blood Institute-Sponsored Studies. (2019) (3)
Augmentation Therapy for Alpha-1 Antitrypsin Deficiency: Improved Survival and Quality of Life Compared to Matched Augmentation Naive Controls Followed for Up to 15 Years (2020) (3)
COPD in the never-smoker (2004) (3)
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study. (2020) (3)
Chronic airflow obstruction and ambient particulate air pollution (2021) (3)
Classification of radiographs for pneumoconiosis: A comparison of digitized images and conventional radiographs (1993) (3)
COPD at work: exposures are different than in the past, but still matter (2018) (3)
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study. (2020) (3)
Using Big Data to Reveal Chronic Respiratory Disease Mortality Patterns and Identify Potential Public Health Interventions. (2017) (3)
Lung function defects in treated pulmonary tuberculosis patients (2016) (3)
A Tiered, Economical Approach For COPD Case-finding In The General Population (2010) (3)
Tobacco industry ownership of pharmaceutical companies: an international survey of people with respiratory disease (2022) (2)
InforMing the PAthway of COPD Treatment Single-Inhaler Triple Therapy (Fluticasone Furoate/ Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium /Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions. (2020) (2)
COPD and lung cancer among women: an equal opportunity risk? (2009) (2)
Patterns And Outcomes Of Non-Invasive Positive-Pressure Ventilation For Acute Exacerbations Of COPD In The US (2011) (2)
Tobacco smoke, malignancies, and history. (2010) (2)
Precision medicine in chronic obstructive pulmonary disease: how far have we come? (2021) (2)
Insights into the Spectrum of Chronic Lower Respiratory Disease: Low Lung Function Is Still Bad (2021) (2)
The future of nature versus nurture in understanding chronic obstructive pulmonary disease. (2013) (2)
How Well Does CAPTURE Translate?: An Exploratory Analysis of a COPD Case‐Finding Method for Spanish‐Speaking Patients (2017) (2)
Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test (2020) (2)
Update on the management of chronic obstructive pulmonary disease (2010) (2)
Tobacco industry ownership of pharmaceutical companies: an international survey of people with respiratory disease (2022) (2)
Childhood asthma hospitalization (2000) (2)
"Haeso cheonsik" and chronic obstructive pulmonary disease in Korea. (2005) (2)
Pulmonary Disease Board Review Manual: Epidemiology and evaluation of Chronic Obstructive Pulmonary Disease (2003) (2)
How Well Does CAPTURE Translate?: An Exploratory Analysis of a COPD Case‐Finding Method for Spanish‐Speaking Patients (2017) (2)
Emergency department visits and hospitalizations for respiratory disease on the Island of Hawaii, 1981-1991: Annual trends on the island of Hawaii and Weekly Variability in Hilo (1996) (2)
Self-reported asthma prevalence among high school students in the United States–2003 (2005) (2)
Impact of Donor Lung Pathogenic Bacteria on Patient Outcomes in the Immediate Post-transplant Period (2018) (2)
Clinical Development and Research Applications of the COPD Assessment Test (CAT). (2019) (2)
Use of a Cross-Sectional Survey in the Adult Population to Characterize Persons at High-Risk for Chronic Obstructive Pulmonary Disease (2019) (1)
Health Disparities in Chronic Obstructive Pulmonary Disease (2016) (1)
Is vitamin D's "moment in the sun" behind us? (2014) (1)
Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey [Corrigendum] (2017) (1)
Fractional Dynamics Foster Deep Learning of COPD Stage Prediction (2023) (1)
Is it Time to Abandon the Post-Bronchodilator Requirement in Defining COPD? (2022) (1)
Considerations Regarding the Epidemiology and Public Health Burden of Asthma (2010) (1)
COPD9USA June 2015. (2015) (1)
Second-hand smoke exposure and blood lead levels in U.S. children: Data from the Third National Health and Nutrition Examination (2003) (1)
Defining and targeting health disparities in COPD Health disparities in respiratory diseases (2016) (1)
METABOLIC DEMAND, VENTILATION AND MUSCLE FUNCTION DURING REPLETION OF MALNOURISHED COPD AND SURGICAL PATIENTS (1985) (1)
Association of respiratory symptoms and lung function with occupation in the multinational Burden of Obstructive Lung Disease (BOLD) study (2022) (1)
The COPD Foundation Coronavirus Disease 2019 International Medical Experts Survey: Results. (2020) (1)
THE BRONCHIECTASIS RESEARCH REGISTRY: CLINICAL, MICROBIOLOGIC, AND TREATMENT CHARACTERISTICS (2010) (1)
EFFECT OF ONCE-DAILY SINGLE-INHALER FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL TRIPLE THERAPY ON SEVERE EXACERBATION RATES COMPARED WITH TWICE-DAILY BUDESONIDE/FORMOTEROL DUAL THERAPY IN PATIENTS WITH COPD: A POST HOC ANALYSIS OF THE FULFIL STUDY (2021) (1)
Protocol Summary of the CAPTURE Validation in Primary Care Study. (2020) (1)
A Novel Non-Invasive Method Of Measuring Exercise Chest Wall Tidal Volumes By Optoelectronic Plethysmography (OEP): Validation Against Simultaneous Spirometry (2012) (1)
Identifying Patients With Undiagnosed Clinically-Significant COPD in Primary Care: What Questions Should We Be Asking? (2015) (1)
Is Systemic Inflammation Responsible for Pulmonary Hypertension in COPD (2015) (1)
Surgical risk, functional outcomes, and late survival after lung volume reduction surgery (LVRS): Report of one hundred consecutive surgical cases (2015) (1)
REFRACTORY NONTUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE: DESCRIPTIVE ANALYSIS FROM THE UNITED STATES BRONCHIECTASIS AND NTM RESEARCH REGISTRY (2021) (1)
Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis (2022) (1)
Is It Time to Abandon the Postbronchodilator Requirement in Defining Chronic Obstructive Pulmonary Disease? (2022) (1)
Health-Related Quality of Life among Adults with Chronic Obstructive Pulmonary Disease. (2009) (1)
Outcomes Important to Patients Diagnosed with Both COPD and Sleep Apnea: Findings from the O2VERLAP Study Focus Groups. (2021) (1)
Implementation Of A Discharge Bundle To Lower COPD Readmissions (2012) (1)
World COPD Day 2008: where have we been and where are we headed? (2008) (1)
Research race-specific reference values and lung function impairment, breathlessness and prognosis: Analysis of NHANES 2007–2012 (2022) (1)
Race-adjusted Lung Function Increases Inequities in Diagnosis and Prognosis and Should Be Abandoned (2022) (1)
Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial (2022) (1)
Identifying Patients With Undiagnosed Clinically-Significant COPD in Primary Care: What Questions Should We Be Asking? (2015) (1)
Treatment Patterns for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Results from an Observational Cross-Sectional Physician and Patient Survey (2022) (1)
Validation of the Lung Function Questionnaire: A Screening Tool To Identify Airflow Obstruction. (2009) (1)
Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data (2018) (1)
Asthma mortality in the United States has risen but is similar to that in England and Wales (1997) (1)
ADRB 2 Arg 16 Gly Polymorphism , Lung Function , and Mortality : Results from the Atherosclerosis Risk in Communities Study (2007) (1)
Searching for COPD: Are Questionnaires the Answer? (2010) (1)
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings. (2023) (1)
LUNG VOLUME REDUCTION SURGERY IMPROVES THE BODE INDEX (2005) (1)
Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study. (2023) (1)
The Changing Definition and Perception of COPD (2022) (1)
The Association of Chronic Macrolide Treatment and Incident Isolation of Non-Tuberculous Mycobacteria in Patients with Bronchiectasis (2020) (1)
SERIES ''THE GLOBAL BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE'' Edited by K.F. Rabe and J.B. Soriano Number 3 in this Series The natural history of chronic obstructive pulmonary disease (2006) (1)
Preventing COPD: Evidence of Progress (2011) (1)
Protocol Summary of the CAPTURE Validation in Primary Care Study. (2020) (1)
Interventions to reduce rehospitalizations following COPD exacerbations: a systematic review (2014) (1)
Home-Based Multicomponent Intervention Increases Exercise Activity and Improves Body Mass Index: Results of a 5-Year Randomized Trial Among Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease. (2020) (1)
COPD9USA June 2015. (2015) (1)
Out of the Ivory Tower, Into the Real World (2008) (1)
Setting standards for pulmonary function measurements: what is reasonable? (2009) (1)
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings. (2023) (1)
Attitudes of Primary Care Physicians Regarding COPD Guidelines. (2009) (1)
Patient and Clinical Demographics of New Users to Single-Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease (2022) (1)
Asthma, COPD and their overlap: coexistence or something more? (2021) (1)
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation (2022) (1)
Symptom Burden and Medication Use Among Patients With Nontuberculous Mycobacterial Lung Disease. (2021) (1)
SERIES “THE GLOBAL BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE” #1: Epidemiology and costs of chronic obstructive pulmonary disease (2006) (1)
Marty Driesler Lung Cancer Project: Preliminary Report Of Lung Cancer Screening In Rural Kentucky (2011) (1)
Airway Clearance in Non-Cystic Fibrosis Bronchiectasis: Analysis from the United States Bronchiectasis Research Registry (2019) (0)
Exactly what is restrictive spirometry capturing? (2017) (0)
The CAPTURE Study: Prevalence of Chronic Obstructive Pulmonary Disease in Primary Care Settings (2020) (0)
Are atopic symptoms associated with increased airway responsiveness in coal miners (1991) (0)
CPH601 Chapter 3 Risk Assessment (2013) (0)
Restricted spirometry through the lifespan (2021) (0)
Summary of the literature assessing a relationship between fibrinogen and chronic obstructive pulmonary disease ( COPD ) (2013) (0)
Long-term Stability of SGRQ Total Score in Individuals With AATD-associated Lung Disease Participating in Alphanet's Disease Management Program (2023) (0)
Impact of SARS-CoV2 Pandemic on Pragmatic Study Outcomes (2023) (0)
Original article Prevalence of COPD among symptomatic patients in a primary care setting (2009) (0)
CPH601 Chapter 11 Transboundary Health/Global Health (2013) (0)
Does Race Adjustment in Pulmonary Function Testing Obscure Important Disparities? (2020) (0)
Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials (2021) (0)
COPD_A_340794 749..761 (2022) (0)
National vehicle emissions policies and practices and declining carbon monoxide-related mortality in the United States, 1968 to 1998 (2002) (0)
Comparison of the Difference in Nephrotoxicity between Nafcillin and Piperacillin-Tazobactam (2019) (0)
RESPIRATORY SYMPTOM ASSESSMENT OF PATIENTS SEEN IN A PRIMARY CARE SETTING (2020) (0)
Preventing Chronic Disease I Adverse Childhood Experiences and Adult Smoking , Nebra (2017) (0)
CPH601 Chapter 4 Risk Management (2013) (0)
Utility of the Modified CRB Score in Predicting Site of Care and Disease Severity in Patients With Sepsis Presenting to the Emergency Department (2017) (0)
Urinary Cadmium Predicts Lower Lung Function in Current and Former Smokers: Data From the Third National Health and Nutrition Examination Survey (2003) (0)
Prevalence and Population Attributable Risk for Early COPD in US Hispanics/Latinos. (2021) (0)
Every breath we take (1999) (0)
P202 CAPTAIN STUDY: TREATMENT OUTCOMES FROM FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL ACCORDING TO HISTORY OF SEVERE ASTHMA EXACERBATIONS (2020) (0)
Identification of Health Data Needed for Assessing Health Effects of Air Pollution Exposures in Multi-Site Studies (2004) (0)
CPH601 Chapter 8 Human Settlement and Urbanization (2013) (0)
Risk factors for acute respiratory distress syndrome in the United States: Analysis of the 1993 national Mortality Followback Study (2001) (0)
Infection and Screening Costs Related to Tumor Necrosis Factor-Alpha Inhibitor Use (2015) (0)
In-hospital mortality, length of stay, and charges related to pulmonary fibrosis in the U.S. between 1993 and 2008 (2016) (0)
CPH601 Chapter 9 Health and Energy Use (2013) (0)
CPH601 Chapter 6 Water (2013) (0)
Feasibility of Screening Electronic Health Records to Identify Participants for a Multi-Center Clinical Effectiveness Trial in COPD (2019) (0)
Spirometry in 2022: Is a Single Set of Prediction Equations for All the Best Path Forward? (2023) (0)
Asthma phenotypes in US children: Findings from the third national health and nutrition examination survey (2004) (0)
Sample of US Children Asthma Phenotypes, Risk Factors, and Measures of Severity in a National (2006) (0)
Research The role of body mass index and diabetes in the development of acute organ failure and subsequent mortality in an observational (2006) (0)
Disease Burden and Quality-of-Life (QoL) for Chronic Obstructive Pulmonary Disease (COPD) in the US - Evidence From the Medical Expenditure Panel Survey (MEPS) From 2016-2019 (2023) (0)
Characteristics Associated With SGRQ in Alpha-1 Antitrypsin Deficiency-associated Lung Disease: A Cross-sectional Analysis (2023) (0)
PATIENT-REPORTED PULMONARY SYMPTOMS AND EXACERBATIONS IN A COHORT OF PATIENTS WITH ALPHA-1 ANTITRYPSIN DEFICIENCY (2021) (0)
CAPTAIN STUDY: ASSOCIATION OF MODERATE AND SEVERE ASTHMA EXACERBATIONS WITH LUNG FUNCTION AND PATIENT-REPORTED OUTCOMES IN A LARGE RANDOMIZED PHASE III CLINICAL TRIAL (2020) (0)
Chronic obstructive pulmonary disease and poverty: an association that respects no borders. (2020) (0)
THE PATIENT'S JOURNEY THROUGH COPD TREATMENT (2021) (0)
Impact of Hospital Transfers on Mortality in an Intensive Care Unit of Central Kentucky (2011) (0)
CPH601 Chapter 7 Food and Agriculture (2013) (0)
FewerHospitalizationsforChronicObstructivePulmonary DiseaseinCommunitiesWithSmoke-FreePublicPolicies (2014) (0)
LATE-BREAKING ABSTRACT: A novel approach for identifying patients with undiagnosed clinically-significant COPD (2015) (0)
Quality of Life and Mortality Outcomes for Augmentation Naïve and Augmented Patients with Severe Alpha-1 Antitrypsin Deficiency. (2023) (0)
Atopy as a Predictor of Mortality: Findings from the Third National Health and Nutrition Examination Survey (NHANES III) (2009) (0)
Syllabus - CPH 911 Epidemiology Seminar I (2012) (0)
Chronic Obstructive Pulmonary Diseases (2014) (0)
CPH601 Chapter 10 Industrial Pollution and Chemical Safety (2013) (0)
High Quality Spirometry Can Be Performed at Diverse Primary Care Practice Based Research Network Sites (2020) (0)
CAPTAIN STUDY: EFFECT OF BASELINE LUNG FUNCTION ON RESPONSE TO TRIPLE THERAPY IN PATIENTS WITH ASTHMA INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID/LONG-ACTING BETA2-AGONIST THERAPY (2020) (0)
Resveratrol Reduces Arterial Stiffness and Improves Functional Capacity in Patients with COPD (2022) (0)
CADMIUM EXPOSURE AND RESIDENCE-TO-ROAD PROXIMITY IN EASTERN KENTUCKY (2018) (0)
Reply to Londhe et al.: CAPTURE: A Screening Tool for Chronic Obstructive Pulmonary Disease or Obstructive Airway Disease? (2018) (0)
Faculty Opinions recommendation of Adherence to inhaled therapy, mortality and hospital admission in COPD. (2009) (0)
A review of epidemiologic evidence of human health effects related to power plant-generated air pollution (1995) (0)
Do We Now Have a ‘Couch Potato' Blood Test? (2012) (0)
Asthma, COPD, And Mortality In The Us Population (2011) (0)
Update on Occupational COPD 1 Occupational COPD : An Update (2016) (0)
Race and Sex Differences in Mortality in Individuals with Chronic Obstructive Pulmonary Disease. (2022) (0)
Syllabus - CPH601-401 Environmental Health (2013) (0)
CAPTAIN: Effects of Body Mass Index (BMI) on Response to Triple Therapy in Patients With Inadequately Controlled Asthma on Inhaled Corticosteroids/Long-acting β2-agonists (ICS/LABA) (2021) (0)
Health hazard evaluation report, HETA 91-131/193-2261, EPA Superfund Site, Newark, New Jersey (1992) (0)
Air pollution and health: what the Georgia physician should know (1999) (0)
EFFECT OF AGE ON EFFICACY AND SAFETY OF ONCE-DAILY SINGLE-INHALER TRIPLE THERAPY FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL IN PATIENTS WITH COPD: A POST-HOC ANALYSIS OF THE IMPACT TRIAL (2019) (0)
Pseudomonas Aeruginosa Associated with Severity of Non-Cystic Fibrosis Bronchiectasis Measured by the Modified Bronchiectasis Severity Score (BSI) and the FACED: The US Bronchiectasis and NTM Research Registry (BRR) Study (2019) (0)
Pulmonary tuberculosis and forced vital capacity (FVC): Results from the BOLD study (2011) (0)
Respiratory symptoms: a reason to obtain spirometry. (2006) (0)
Impact of Socioeconomic Factors and Outcomes From Intensive Care in an Underserved Area of Kentuck (2011) (0)
Inflammatory Profiles Are Different in Heart Failure Patients with and without COPD (2007) (0)
Race-Sex Disparities in Cardiovascular Mortality for Participants with Chronic Obstructive Pulmonary Disease (COPD) in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Cohort (2021) (0)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), COMORBID DISEASE, AND FOLLOW-UP HOSPITALIZATIONS IN A U.S. COHORT (2007) (0)
Characteristics of COPD Patients reporting Alpha-1 Antitrypsin Deficiency in the Lung Disease Health Check Database (2013) (0)
The Launch of a New COPD Journal. (2014) (0)
Chronic Obstructive Pulmonary Diseases : Journal of the COPD Foundation Effects of GOLD-Adherent Prescribing on COPD Symptom Burden , Exacerbations , and Health Care Utilization in a Real-World Setting (2015) (0)
Interstate asthma prevalence variability exists, but is it for real and does it matter? (2004) (0)
Chronic obstructive pulmonary disease and the role of spirometry (2008) (0)
3-14-2007 ADRB 2 Arg 16 Gly polymorphism , lung function , and mortality : results from the Atherosclerosis Risk in Communities study (2017) (0)
Using the lower limit of normal to classify lung disease misses at risk people (2011) (0)
SUN-PP159: The Relationship between Dietary Fiber Intake Low Fev1 in Nhanes (2015) (0)
CPH601 Chapter 2 Toxicology (2013) (0)
P206 CAPTAIN STUDY: EFFECTS OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL ON FEV1 IMPROVEMENT IN ASTHMA ACCORDING TO AGE (2020) (0)
Long‐term trends of COPD mortality: Gaps and opportunities (2022) (0)
Incidence of Severe Cardiovascular Events Following Acute Exacerbation of Chronic Obstructive Pulmonary Disease in a Large Claims Database (2023) (0)
Lung function impairment in the never-smoker: the search for answers continues. (2015) (0)
Correlates of Restriction on Spirometry in the Burden of Lung Disease (BOLD) Study. (2009) (0)
AN ANALYSIS OF PRE- AND POSTBRONCHODILATOR LUNG FUNCTION IN THE DEFINITION OF COPD: WHAT IS REVERSIBILITY? (2009) (0)
Data of physiological measurements and quality of life in subjects with mild to moderate COPD compared to asymptomatic current smokers, former smokers (2017) (0)
Chapter 5. Chronic Obstructive Pulmonary Disease (COPD) (2010) (0)
Fractional Dynamics Foster Deep Learning of COPD Stage Prediction (Adv. Sci. 12/2023) (2023) (0)
Factors Associated With A Higher CCQ Score In Patients With COPD From The US COPD REVEALED Survey (2010) (0)
COVID-19 DATA FROM THE PRIMARY CARE POPULATION OF THE CAPTURE STUDY (2021) (0)
Dairy farming production in the United States and deaths with farmers lung disease from 1979-1986: an ecological study. (1990) (0)
1487: USE OF ARB-BICARBONATE SCORE TO PREDICT SITE OF CARE IN PATIENTS WITH SEPSIS (2018) (0)
Epidemiology of COPD (2012) (0)
Reversibility Of Obstruction, Significant Bronchodilator Responsiveness, And Mortality In The Lung Health Study (2012) (0)
Characterization of sociodemographic and health characteristics of USA adults with frequent respiratory symptoms (2017) (0)
Race-ethnicity as an Effect Modifier of the Association between Glycated Hemoglobin and Mortality in U.S. Adults without Diagnosed Diabetes Short running title: Race-ethnicity modifies effect of GHb on mortality (2011) (0)
CPH601 Chapter 1 Introduction (2013) (0)
Bronchodilator Responsiveness From 14 Countries: Population-based Rates And Correlates From The Burden Of Obstructive Lung Disease (BOLD) Study (2010) (0)
Respiratory Symptoms among US Adults: a Cross-Sectional Health Survey Study (2022) (0)
Patient-Reported Pulmonary Symptoms, Exacerbations, and Management in a Cohort of Patients With Alpha-1 Antitrypsin Deficiency. (2022) (0)
Chronic obstructive pulmonary disease : A global disease with important local variation (2013) (0)
Disease Co-Morbidities in a Subject Population with a History of Cigarette Smoking and Symptoms of Chronic Bronchitis as Potential Precursors of COPD. (2009) (0)
Chronic Obstructive Pulmonary Disease Morning Symptom Diary (2016) (0)
Can Peak Flow (PEF) Aid in the Identification of Undiagnosed Clinically-Significant COPD? (2015) (0)
Factors Associated With Heart Disease As A Co-morbidity In Patients With COPD From The US COPD REVEALED Survey (2010) (0)
A new paradigm for classification of disease severity and progression of COPD (2012) (0)
CROSS-SECTIONAL SURVEY TO ASSESS COPD MEDICATION USE BY UNITED STATES PHYSICIANS (2020) (0)
COPD (2018) (0)
RESEARCH WATCH AIR QUALITY Oxygenated fuels (2010) (0)
Research Watch: Effects of load reduction on bioaccumulation. (1996) (0)
Use of a USA population survey to describe tobacco exposure, respiratory symptoms, and chronic diseases among smokers (2014) (0)
RECENT TRENDS IN EXPOSURE TO SECONDHAND SMOKE IN THE UNITED STATES (US) POPULATION (2008) (0)
Prevalence of COPD-Defined Airflow Obstruction in Undiagnosed Subjects with Symptoms of Chronic Bronchitis in Primary Care. (2009) (0)
CAN THE PM2.5-INDUCED HEART RATE VARIABILITY CHANGES BE PREVENTED? RESULTS FROM A RANDOMIZED STUDY OF FISH AND SOY OIL SUPPLEMENTATION (2004) (0)
Frailty Features Are Common in Ambulatory Patients with COPD and May Be Associated with Respiratory Muscle Weakness (2017) (0)
Factors Associated With Congestive Heart Failure As A Co-morbidity In Patients With COPD From The U.S. COPD REVEALED Survey (2010) (0)
The clinical course of COPD: earlier intervention (2009) (0)
CAPTAIN: Effects of Cardiovascular Risk on Response to Triple Therapy in Patients With Inadequately Controlled Asthma on Inhaled Corticosteroids/Long-acting β2-agonists (ICS/LABA) (2021) (0)
Rebuttal From Drs Mannino and Thomashow. (2020) (0)
A Survey of the Prevalence and Impact of Chronic Obstructive Pulmonary Disease (COPD) and Asthma in North Carolina (NC). (2009) (0)
Definition of COPD GOLD stage I. Authors' reply (2007) (0)
Factors Predicting Comorbid Asthma Among Patients With COPD From The U.S. COPD Revealed Survey (2010) (0)
DEVELOPMENT OF THE LUNG FUNCTION QUESTIONNAIRE: A SCREENING TOOL TO IDENTIFY AIRFLOW OBSTRUCTION (2008) (0)
PREVALENCE OF COPD-DEFINED AIRFLOW OBSTRUCTION IN UNDIAGNOSED PRIMARY CARE SUBJECTS WITH SYMPTOMS OF CHRONIC BRONCHITIS (2008) (0)
Fibrinogen and all-cause mortality in a nationally representative US cohort (2011) (0)
Correction: Race-specific reference values and lung function impairment, breathlessness and prognosis: analysis of NHANES 2007–2012 (2023) (0)
Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency: A Randomized Crossover Study (2021) (0)
Chronic Obstructive Pulmonary Diseases : Journal of the COPD Foundation COPD 10 usa 2017 (2017) (0)
CPH601 Chapter 12 Action (2013) (0)
How I Review a Paper to Help Improve Citability and Impact. (2021) (0)
Pulmonary cavitary lesion and haemoptysis: rare aetiology on biopsy (2016) (0)
Comparing quality measures during hospitalization for chronic obstructive pulmonary disease in 2005-06 and 2010 (2014) (0)
Differences In Ventilatory Inefficiency Among Patients With Varying Disease Severity Of Chronic Obstructive Pulmonary Disease (2012) (0)
EFFECT OF ONCE-DAILY SINGLE-INHALER FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL TRIPLE THERAPY ON EXACERBATIONS COMPARED WITH BUDESONIDE/FORMOTEROL DUAL THERAPY IN PATIENTS WITH COPD AND NO HISTORY OF EXACERBATIONS: A POST HOC ANALYSIS OF THE FULFIL STUDY (2021) (0)
Improved Outcomes After Lung Volume Reduction After NETT (2010) (0)
P-207APICAL PERFUSION FRACTION MAY NOT BE A PREDICTOR OF FUNCTIONAL OUTCOMES FOLLOWING BILATERAL LUNG VOLUME REDUCTION SURGERY (2016) (0)
Prevalence And Clinical Significance Of Mucoid Pseudomonas Aeruginosa Infection In Adults With Non-Cystic Fibrosis Bronchiectasis - Results From The Bronchiectasis Research Registry (2011) (0)
Post-pulmonary rehabilitation exercise adherence and exercise performance in COPD and ILD (2017) (0)
Characteristics of COPD Patients reporting Alpha-1 Antitrypsin Deficiency in the Lung Disease Health Check Database (2013) (0)
Response to the Letter to the Editor (2015) (0)
New Statistics on the US Epidemic in "COPD Mortality: That Was Then - This Is Now!" (2003) (0)
PCCU-Lesson 23 COPD in the Never-Smoker (2017) (0)
Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease (2023) (0)
Atypical Case of Pulmonary Lymphangioleiomyomatosis (2021) (0)
Correlates Of Fibrinogen Levels (Total And Elevated) In A US Cohort (2011) (0)
Guiding principles for COPD treatment. (2014) (0)
Durability of Benefit of Lung Volume Reduction Surgery: 3 and 4 Year Follow-Up after NETT. (2009) (0)
Does lung volume reduction surgery improve chronotropic incompetence in chronic obstructive pulmonary disease (COPD) patients (2011) (0)
Disconnects in Physician and Patient Perceptions of COPD Disease Assessment (2017) (0)
Adaptations In Chest Wall Kinematics During Maximum Exercise In Elite Cyclists And Triathletes By Optoelectronic Plethysmography (2010) (0)
Racial Differences in Smoking Intensity in the Genetic Epidemiology of COPD (COPDGene® Study). (2009) (0)
Red Cell Transfusion and Mortality of MICU Patients Receiving Continuous Renal Replacement Therapy (2016) (0)
Impact of SARS-CoV2 Pandemic on Pragmatic Study Outcomes (2023) (0)
Management of Pulmonary Exacerbations in a Cohort of Patients with Alpha-1 Antitrypsin Deficiency (2022) (0)
The Bronchiectasis Research Registry: The Added Perspective Of Changes Over Time, A Resource For Collaborative Research In Non-Cystic Fibrosis Bronchiectasis (2011) (0)
Selection of Candidates for Lung Volume Reduction Surgery (2002) (0)
Functional Outcomes Long Term Survival and Surgical Risk After Lung Volume Reduction Surgery: A 12-year Single Center Experience (2017) (0)
COPD Assessment Test (CAT) Score Is Associated with Risk of Future Exacerbation: An Analysis from the IMPACT Trial (2019) (0)
Comparing Clinical Characteristics and Outcomes in Patients with Non-Cystic Fibrosis Bronchiectasis with Non-Tuberculous Mycobacteria and/or Pseudomonas Aeruginosa Within the US Bronchiectasis and NTM Research Registry (2020) (0)
LATE-BREAKING ABSTRACT: A novel approach for identifying patients with undiagnosed clinically-significant COPD (2015) (0)
CT screening for early stage lung cancer. (2002) (0)
In Gratitude to James D. Crapo. (2020) (0)
Air pollution and health: what Georgia physicians should know. (1999) (0)
[Prevention of avitaminosis due to antibiotics; experimental studies on healthy subjects and clinical observations on sick]. (1955) (0)
Reply to Londhe et al.: CAPTURE: A Screening Tool for Chronic Obstructive Pulmonary Disease or Obstructive Airway Disease? (2018) (0)
What Are Our Patients with Chronic Obstructive Pulmonary Disease Really Taking? (2020) (0)
What Patients Report Regarding Chronic Obstructive Pulmonary Disease Medication Adherence (2020) (0)
Comparative efficacy and safety of surgical and bronchoscopic approaches to lung volume reduction (2017) (0)
Late-breaking abstract: Sildenafil for chronic obstructive pulmonary disease: A randomized crossover trial (2011) (0)
The Bronchiectasis Research Registry: A Resource For Collaborative Research In Non-Cystic Fibrosis Bronchiectasis (2010) (0)
Pseudomonas Aeruginosa Associated with Severity of Non-Cystic Fibrosis Bronchiectasis Measured by the Modified Bronchiectasis Severity Score (BSI) and the FACED: The US Bronchiectasis and NTM Research Registry (BRR) Study (2019) (0)
What Do Our Patients Report About Using Nebulizers for Chronic Obstructive Pulmonary Disease Management (2020) (0)
Abstract Presentations: COPD10usa 2017. (2017) (0)
Comparison of the Management of Patients Hospitalized for COPD Exacerbation in Urban vs. Community Hospitals. (2009) (0)
A Real-World Study Assessing the Medical Cost Burden of Chronic Obstructive Pulmonary Disease (COPD) in the United States From 2016-2019 and Projections Through 2029: Analysis of Medical Expenditure Panel Survey (MEPS) Data (2023) (0)
Chronic Obstructive Pulmonary Diseases : Journal of the COPD Foundation COPD 10 usa 2017 (2017) (0)
Treatment Options in Asthma and COPD Overlap Syndrome (2011) (0)
Letter to Editor Regarding the OCEAN Study [Letter] (2021) (0)
Can Peak Flow (PEF) Aid in the Identification of Undiagnosed Clinically-Significant COPD? (2015) (0)
Association between Comorbidity on Readmission and Discharge to Skilled Nursing Facilities in Patients Hospitalized for COPD Exacerbation. (2009) (0)
Frailty Features Are Common in Ambulatory Patients with COPD and May Be Associated with Respiratory Muscle Weakness (2017) (0)
Rebuttal From Drs Mannino and Thomashow. (2020) (0)
BODE Index before and after LVRS is associated with long term survival in a post-NETT cohort (2016) (0)
Pulmonary Nontuberculous Mycobacterial Infection in Patients in the U.S. Bronchiectasis Research Registry: Use of Antibiotic Therapy and Adverse Events (2020) (0)
Forced Vital Capacity And Amyotrophic Lateral Sclerosis Revised Functional Rating Scale Predicts Ventilatory Mechanics During Maximal Voluntary Ventilation In Patients With Amyotrophic Lateral Sclerosis (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David M. Mannino?

David M. Mannino is affiliated with the following schools:

David M. Mannino's Academic­Influence.com Rankings

David M. Mannino's Degrees

Why Is David M. Mannino Influential?

David M. Mannino's Published Works

Published Works

What Schools Are Affiliated With David M. Mannino?

David M. Mannino's AcademicInfluence.com Rankings